Hematology. American Society of Hematology. Education Program Journal

Overview
Identity
View All

publication venue for

Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding. 2019:204-208. 2019
Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department. 2019:323-326. 2019
Management of iron deficiency. 2019:315-322. 2019
What we have learned about direct oral anticoagulant reversal. 2019:198-203. 2019
How do we diagnose immune thrombocytopenia in 2018?. 2018:561-567. 2018
Using pharmacokinetics to individualize hemophilia therapy. 2017:595-604. 2017
Prevention of thrombosis in antiphospholipid syndrome. 2016:707-713. 2016
Reversal of direct oral anticoagulants: a practical approach. 2016:612-619. 2016
Thrombosis and anticoagulation in the setting of renal or liver disease. 2016:188-195. 2016
What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?. 2016:714-716. 2016
Bleeding complications in immune thrombocytopenia. 2015:237-242. 2015
Monitoring and reversal of direct oral anticoagulants. 2015:117-124. 2015
Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review. 2015:448-453. 2015
Anticoagulation and in vitro fertilization and ovarian stimulation. 2014:379-386. 2014
What is the effect of rivaroxaban on routine coagulation tests?. 2014:334-336. 2014
Antiphospholipid syndrome. 2013:675-680. 2013
Phase 4 research: what happens when the rubber meets the road?. 2013:15-18. 2013
Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism?. 2013:681-683. 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. 2013:9-14. 2013
Updates in thrombosis in pediatrics: where are we after 20 years?. 2012:439-443. 2012
New oral anticoagulants: which one should my patient use?. 2012:536-540. 2012
Pharmacologic tools to reduce bleeding in surgery.. 2012:517-521. 2012
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.. 2012:313-321. 2012
How I Diagnose and Manage HIT. 2011:143-149. 2011
Rajasekhar A, Crowther MA. ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients? Hematology Am Soc Hematol Educ Program. 2009;2009:302-304.. 2011:561-561. 2011
Consultative Hematology: The Pregnant Patient Pregnancy Loss. 2010:166-172. 2010
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?. 2009:247-249. 2009
ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients?. 2009:302-304. 2009
Antiphospholipid antibody syndrome. 2009:233-239. 2009
Introduction to surrogates and evidence-based mini-reviews. 2009:15-16. 2009
Does Helicobacter pylori Eradication Therapy Result in a Platelet Count Improvement in Adults with Immune Thrombocytopenic Purpura Regardless of H pylori Infection?. 2008:31-32. 2008
Evidence-Based Guidelines—An Introduction. 2008:26-30. 2008
Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists. 2008:266-270. 2008
New Strategies for the Optimal Use of Platelet Transfusions. 2008:198-204. 2008
What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?. 2008:36-38. 2008
Hematopoietic Development from Human Embryonic Stem Cells. 2007:11-16. 2007
Management of Pregnant Women with Thrombophilia or a History of Venous Thromboembolism. 2007:143-150. 2007
Trials and Tribulations of Systematic Reviews and Meta-Analyses. 2007:493-497. 2007
The Management of Patients with Limited-Stage Classical Hodgkin Lymphoma. 2006:253-258. 2006
Think of HIT. 2006:408-414. 2006
Diagnosis and Management of Mild Bleeding Disorders. 2005:423-428. 2005
Pathogenesis of Atherosclerosis. 2005:436-441. 2005
Hodgkin’s Lymphoma: Evolving Concepts with Implications for Practice. 2004:184-202. 2004
Thrombophilia and New Anticoagulant Drugs. 2004:424-438. 2004
Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation. 2003:575-589. 2003
Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome. 2003:497-519. 2003
Thrombotic Disorders: Diagnosis and Treatment. 2003:520-539. 2003
Anticoagulation Therapy. 2001:339-357. 2001
Thromboembolic Disease and Antithrombotic Therapy in Newborns. 2001:358-374. 2001
Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism. 2000:266-284. 2000